Zobrazeno 1 - 10
of 45
pro vyhledávání: '"letizia gianoncelli"'
Autor:
Serena Petrocchi, Rosanne Janssens, Serena Oliveri, Reinhard Arnou, Ilaria Durosini, Paolo Guiddi, Evelyne Louis, Marie Vandevelde, Kristiaan Nackaerts, Meredith Y. Smith, Giulia Galli, Filippo de Marinis, Letizia Gianoncelli, Gabriella Pravettoni, Isabelle Huys
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: The potential value of patient preference studies has been recognized in clinical individual treatment decision-making between clinicians and patients, as well as in upstream drug decision-making. Drug developers, regulators, reimbursemen
Externí odkaz:
https://doaj.org/article/c6573583d5d9442db29de6fbae3ec65d
Publikováno v:
Patient Experience Journal (2020)
When you get ill, the first thing that comes to your mind is, “Will I make it? Will I survive?". COVID19 has a major impact on mental health. A sadness that inundates us like a river in flood and which we cannot hold back. But the thing that tormen
Externí odkaz:
https://doaj.org/article/6de39efdeea945b7a0fb961d07e4b4dd
Autor:
Chiara Catania, Gianluca Spitaleri, Ester Del Signore, Ilaria Attili, Davide Radice, Valeria Stati, Letizia Gianoncelli, Stefania Morganti, Filippo de Marinis
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
In February 2020, Italy became one of the first countries to be plagued by the SARS-CoV-2 pandemic, COVID-19. In March 2020, the Italian government decreed a lockdown for the whole country, which overturned communication systems, hospital organizatio
Externí odkaz:
https://doaj.org/article/c482541459014b8eae0d08837e0da789
Autor:
Filippo de Marinis, Ilaria Attili, Stefania Morganti, Valeria Stati, Gianluca Spitaleri, Letizia Gianoncelli, Ester Del Signore, Chiara Catania, Cristiano Rampinelli, Emanuela Omodeo Salè, Lorenzo Spaggiari, Fabrizio Mastrilli, Antonio Passaro
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
A novel coronavirus causing severe acute respiratory syndrome (SARS), named SARS-CoV-2, was identified at the end of 2019. The spread of coronavirus disease 2019 (COVID-19) has progressively expanded from China, involving several countries throughout
Externí odkaz:
https://doaj.org/article/b166a3ec616645e09a8354bb34f21503
Autor:
Luca Toschi, Giovanna Finocchiaro, Teresa T Nguyen, Margaret C Skokan, Laura Giordano, Letizia Gianoncelli, Matteo Perrino, Licia Siracusano, Luca Di Tommaso, Maurizio Infante, Marco Alloisio, Massimo Roncalli, Marta Scorsetti, Pasi A Jänne, Armando Santoro, Marileila Varella-Garcia
Publikováno v:
PLoS ONE, Vol 9, Iss 4, p e95303 (2014)
We aimed to investigate prevalence and prognostic role of SOX2, PIK3CA, FGFR1 and BRF2 gene gain in patients with surgically resected non-small cell lung cancer (NSCLC).SOX2, PIK3CA, FGFR1 and BRF2 gene copy number was assessed by fluorescence in sit
Externí odkaz:
https://doaj.org/article/86e67c9e69fc44cf9f507eb57c679453
Autor:
Elena Guerini-Rocco, Valeria Stati, Davide Radice, Filippo de Marinis, Ester Del Signore, Antonio Passaro, Letizia Gianoncelli, Chiara Catania, Caterina Fumagalli, Massimo Barberis, Gianluca Spitaleri
Publikováno v:
Anticancer Research. 40:427-433
BACKGROUND/AIM The role of anti-PD1/PD-L1 therapy (IO) in NSCLC harboring driver mutations is questionable. This study aimed to examine the efficacy of IO in patients with non-small cell lung cancer (NSCLC) with a KRAS mutation (KRAS+). PATIENTS AND
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52165fe81f7d89b72427e65f53da6261
https://doi.org/10.21873/anticanres.13970
https://doi.org/10.21873/anticanres.13970
Publikováno v:
Patient Experience Journal (2020)
When you get ill, the first thing that comes to your mind is, “Will I make it? Will I survive?". COVID19 has a major impact on mental health. A sadness that inundates us like a river in flood and which we cannot hold back. But the thing that tormen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a56d1771a2d9212ad3aeb0e7b5567266
https://doi.org/10.35680/2372-0247.1519
https://doi.org/10.35680/2372-0247.1519
Autor:
Giulia Galli, Isabelle Huys, Filippo de Marinis, Kristiaan Nackaerts, Evelyne Louis, Reinhard Arnou, Rosanne Janssens, Paolo Guiddi, Ilaria Durosini, Marie Vandevelde, Serena Petrocchi, Letizia Gianoncelli, Meredith Y. Smith, Serena Oliveri, Gabriella Pravettoni
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology
Frontiers in Pharmacology
Background: The potential value of patient preference studies has been recognized in clinical individual treatment decision-making between clinicians and patients, as well as in upstream drug decision-making. Drug developers, regulators, reimbursemen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6260e4e808504efc8316591e411aca42
https://www.frontiersin.org/articles/10.3389/fphar.2021.602112/full
https://www.frontiersin.org/articles/10.3389/fphar.2021.602112/full
Autor:
Letizia Gianoncelli, Marcello Tiseo, Paolo Pedrazzoli, Antonio Maconi, Federico Cappuzzo, Stefano Frega, Maria Pagano, Giulia Pasello, Matteo Perrino, F. Zanelli, Maria Bonomi, Carmine Pinto, Filippo de Marinis, Luca Boni, Federica Grosso, Armando Santoro, Candida Bonelli, Marina Chiara Garassino, Paolo Andrea Zucali, Francesco Grossi, Giovanni Luca Ceresoli, Erika Gervasi, Hector Soto Parra
Summary Background There is a preclinical rationale for inhibiting angiogenesis in mesothelioma. We aimed to assess the efficacy and safety of the anti-VEGFR-2 antibody ramucirumab combined with gemcitabine in patients with pretreated malignant pleur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78597edc6a57d0d326a538c014d92e8a
http://hdl.handle.net/11383/2125715
http://hdl.handle.net/11383/2125715
Autor:
Gianluca Spitaleri, Ilaria Attili, Stefania Morganti, Letizia Gianoncelli, Valeria Stati, Davide Radice, Ester Del Signore, Chiara Catania, Filippo de Marinis
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology, Vol 10 (2020)
In February 2020, Italy became one of the first countries to be plagued by the SARS-CoV-2 pandemic, COVID-19. In March 2020, the Italian government decreed a lockdown for the whole country, which overturned communication systems, hospital organizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50c712946f6a77a5f00666a628aca430
http://europepmc.org/articles/PMC7591454
http://europepmc.org/articles/PMC7591454